AI Boosts Diabetic Eye Care Access

• May 5, 2026

Update on Diabetic Disease

Upfront: Monthly reflection by Editor in Chief Diana V. Do, MD.

• by Diana V. Do, MD

• May 1, 2026

• 3 min

Marked and reversible circulating insulin-like growth factor-1 elevation during teprotumumab N01 treatment for thyroid eye disease with limited correspondence to glycemic changes

• by Wei Zhao, Lingli Zhou, Ying Gao, Xianghai Zhou, Xueyao Han, Xiuying Zhang, Linong Ji

• July 15, 2026

Diabetic retinopathy and the risk of all-cause dementia, Alzheimer’s disease, and vascular dementia: a systematic review and meta-analysis

• by Haoshen Hu, Yue Wang, Yidan Xu, Lixun Chen

• June 30, 2026